Pacira BioSciences, Inc.
PCRX
$23.00
-$0.18-0.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 251.03M | 202.18M | 238.42M | 246.33M | 445.86M |
| Total Receivables | 141.02M | 133.64M | 124.37M | 115.47M | 114.77M |
| Inventory | 134.58M | 150.37M | 152.86M | 157.68M | 148.16M |
| Prepaid Expenses | 21.25M | 28.78M | 30.62M | 43.27M | 36.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 67.34M | -- | 1.70M | -- | -- |
| Total Current Assets | 615.22M | 514.96M | 547.97M | 562.75M | 745.61M |
|
|
|||||
| Total Current Assets | 615.22M | 514.96M | 547.97M | 562.75M | 745.61M |
| Net Property, Plant & Equipment | 175.20M | 175.69M | 182.47M | 191.65M | 201.71M |
| Long-term Investments | 19.64M | 19.77M | 20.21M | 20.32M | 20.30M |
| Goodwill | 19.64M | 19.77M | 20.21M | 20.32M | 20.30M |
| Total Other Intangibles | 285.48M | 353.23M | 368.10M | 382.40M | 422.56M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 140.69M | 122.12M | 129.85M | 120.19M | 128.27M |
| Total Assets | 1.24B | 1.21B | 1.26B | 1.30B | 1.54B |
|
|
|||||
| Total Accounts Payable | 17.51M | 14.01M | 15.15M | 17.69M | 30.12M |
| Total Accrued Expenses | 80.82M | 73.94M | 84.05M | 79.64M | 71.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.30M | 9.82M | 9.84M | 9.75M | 212.02M |
| Total Finance Division Other Current Liabilities | 13.39M | 11.01M | 11.55M | -- | -- |
| Total Other Current Liabilities | 13.39M | 11.01M | 11.55M | -- | -- |
| Total Current Liabilities | 122.01M | 108.79M | 120.59M | 107.08M | 313.16M |
|
|
|||||
| Total Current Liabilities | 122.01M | 108.79M | 120.59M | 107.08M | 313.16M |
| Long-Term Debt | 363.12M | 367.66M | 372.19M | 376.72M | 378.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 38.70M | 33.71M | 36.18M | 38.84M | 41.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 48.17M | 44.49M | 42.85M | 47.73M | 46.95M |
| Total Liabilities | 572.00M | 554.64M | 571.81M | 570.36M | 779.50M |
|
|
|||||
| Common Stock & APIC | 1.09B | 1.07B | 1.06B | 1.05B | 1.04B |
| Retained Earnings | -191.75M | -196.41M | -199.32M | -200.96M | -206.39M |
| Treasury Stock & Other | -223.77M | -223.56M | -172.24M | -121.42M | -71.45M |
| Total Common Equity | 671.98M | 653.89M | 693.11M | 727.21M | 757.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 671.98M | 653.89M | 693.11M | 727.21M | 757.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 671.98M | 653.89M | 693.11M | 727.21M | 757.77M |
|
|
|||||